Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
4(80.0%)
Phase 2
1(20.0%)
5Total
Phase 1(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03758014Phase 2Unknown

Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients

Role: lead

NCT03751592Phase 1Unknown

Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

Role: lead

NCT02245204Phase 1Completed

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Role: lead

NCT02728349Phase 1Completed

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Role: lead

NCT02136342Phase 1Terminated

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Role: collaborator

All 5 trials loaded